1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer
  4. Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/223051
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPons Cabrera, Maite-
dc.contributor.authorCaballería Lamora, Elsa-
dc.contributor.authorNavarro Cortes, Lourdes-
dc.contributor.authorBorras Amoraga, Roger-
dc.contributor.authorBarrio Giménez, Pablo-
dc.contributor.authorManthey, Jakob-
dc.contributor.authorBatalla Cases, Albert-
dc.contributor.authorOliveras Salvà, Clara-
dc.contributor.authorSagué Vilavella, Maria-
dc.contributor.authorBalcells Oliveró, Mercè-
dc.contributor.authorPintor Pérez, Luis-
dc.contributor.authorLópez Pelayo, Hugo-
dc.date.accessioned2025-09-09T07:21:40Z-
dc.date.issued2025-04-10-
dc.identifier.issn1879-1379-
dc.identifier.urihttps://hdl.handle.net/2445/223051-
dc.description.abstractLittle is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Related Quality of Life (HRQoL), and functioning in 800 medical inpatients at a high-complexity academic hospital. Multivariate analyses demonstrated that psychiatric comorbidities were associated with reduced HRQoL (beta = -0.050, p-value = 0.017), and impaired functioning (beta = 3.4, p-valueca
dc.format.extent32 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherElsevier Ltd.ca
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.jpsychires.2025.04.006-
dc.relation.ispartofJournal Of Psychiatric Research, 2025, vol. 186, 322-330-
dc.relation.urihttps://doi.org/10.1016/j.jpsychires.2025.04.006-
dc.rightscc-by-nc-nd (c) Elsevier, 2025-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)-
dc.subject.classificationComorbiditat-
dc.subject.classificationPsiquiatria-
dc.subject.classificationAbús de substàncies-
dc.subject.otherComorbidity-
dc.subject.otherPsychiatry-
dc.subject.otherSubstance abuse-
dc.titleSubstance use and psychiatric comorbidities among medical inpatients: associations with length of stay, health-related quality of life, and functioning, with consideration for genderca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.date.updated2025-09-08T14:01:09Z-
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccessca
dc.embargo.lift2026-04-10-
dc.date.embargoEndDateinfo:eu-repo/date/embargoEnd/2026-04-10ca
dc.identifier.idimarina9466339-
dc.identifier.pmid40286460-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
JPSYCHIATRRES-D-24-00123_R1.pdf4.56 MBAdobe PDFView/Open    Request a copy
Show simple item record


Embargat   Document embargat fins el 10-4-2026


This item is licensed under a Creative Commons License Creative Commons